ABDULBARI FAROOQI: Open Payments
NPI 1093838286 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 11 payments from 7 companies in 2025. Trend: 2023 $594 · 2024 $479 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $296 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $124 |
| Alkermes, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: COBENFY, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, ARISTADA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
